Bbs Bioactive Bone Substitutes Stock Total Asset
| BONEH Stock | EUR 0.07 0 1.47% |
BBS Bioactive Bone Substitutes fundamentals help investors to digest information that contributes to BBS Bioactive's financial success or failures. It also enables traders to predict the movement of BBS Stock. The fundamental analysis module provides a way to measure BBS Bioactive's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BBS Bioactive stock.
BBS |
BBS Bioactive Bone Substitutes Company Total Asset Analysis
BBS Bioactive's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current BBS Bioactive Total Asset | 10.51 M |
Most of BBS Bioactive's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BBS Bioactive Bone Substitutes is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Based on the latest financial disclosure, BBS Bioactive Bone Substitutes has a Total Asset of 10.51 M. This is 99.86% lower than that of the Healthcare sector and 99.83% lower than that of the Medical Devices industry. The total asset for all Finland stocks is 99.96% higher than that of the company.
BBS Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BBS Bioactive's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BBS Bioactive could also be used in its relative valuation, which is a method of valuing BBS Bioactive by comparing valuation metrics of similar companies.BBS Bioactive is currently under evaluation in total asset category among its peers.
BBS Fundamentals
| Return On Equity | -0.61 | |||
| Return On Asset | -0.15 | |||
| Operating Margin | (278.58) % | |||
| Current Valuation | 14.53 M | |||
| Shares Outstanding | 9.67 M | |||
| Shares Owned By Insiders | 45.74 % | |||
| Shares Owned By Institutions | 1.71 % | |||
| Price To Book | 2.10 X | |||
| Price To Sales | 1,123 X | |||
| Gross Profit | (56.95 K) | |||
| EBITDA | (2.34 M) | |||
| Net Income | (2.77 M) | |||
| Cash And Equivalents | 3.44 M | |||
| Cash Per Share | 0.52 X | |||
| Total Debt | 5.12 M | |||
| Debt To Equity | 0.99 % | |||
| Current Ratio | 5.04 X | |||
| Book Value Per Share | 0.58 X | |||
| Cash Flow From Operations | (2.52 M) | |||
| Earnings Per Share | (0.42) X | |||
| Number Of Employees | 21 | |||
| Beta | -0.0943 | |||
| Market Capitalization | 12.23 M | |||
| Total Asset | 10.51 M | |||
| Z Score | 1.2 | |||
| Net Asset | 10.51 M |
About BBS Bioactive Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BBS Bioactive Bone Substitutes's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BBS Bioactive using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BBS Bioactive Bone Substitutes based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BBS Stock
BBS Bioactive financial ratios help investors to determine whether BBS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BBS with respect to the benefits of owning BBS Bioactive security.